Original Research
Published on 08 Jun 2023
N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways
in Pharmacology of Anti-Cancer Drugs
![N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways](https://www.frontiersin.org/files/myhome article library/1164367/1164367_Thumb_400.jpg)
- 1,334 views
Original Research
Published on 08 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 08 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 08 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 08 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 08 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 07 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 07 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 06 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Editorial
Published on 06 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 02 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 02 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 01 Jun 2023
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Jun 2023
in Pharmacology of Anti-Cancer Drugs